Jill M. Van Dalfsen

1.1k total citations · 2 hit papers
8 papers, 819 citations indexed

About

Jill M. Van Dalfsen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Jill M. Van Dalfsen has authored 8 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Jill M. Van Dalfsen's work include Cystic Fibrosis Research Advances (7 papers), Antibiotic Resistance in Bacteria (2 papers) and Pneumonia and Respiratory Infections (2 papers). Jill M. Van Dalfsen is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Antibiotic Resistance in Bacteria (2 papers) and Pneumonia and Respiratory Infections (2 papers). Jill M. Van Dalfsen collaborates with scholars based in United States, Canada and United Kingdom. Jill M. Van Dalfsen's co-authors include Bonnie W. Ramsey, Steven M. Rowe, Sonya L. Heltshe, Scott D. Sagel, Drucy Borowitz, Nicole Mayer-Hamblett, Scott H. Donaldson, Daniel Gelfond, Tanja Gonska and Elizabeth Joseloff and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and Journal of Clinical Microbiology.

In The Last Decade

Jill M. Van Dalfsen

8 papers receiving 802 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis

2014 375 citations Steven M. Rowe, Sonya L. Heltshe et al. American Journal of Respiratory and Critical Care Medicine profile →
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

2023 106 citations David P. Nichols, Sarah J. Morgan et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill M. Van Dalfsen United States	7	691	160	129	92	85	8	819
A Equi United Kingdom	6	421 0.6×	92 0.6×	176 1.4×	41 0.4×	56 0.7×	7	541
Bridget K. Foster United States	6	469 0.7×	354 2.2×	124 1.0×	56 0.6×	52 0.6×	6	638
Valerie J. Waters Canada	11	368 0.5×	173 1.1×	88 0.7×	39 0.4×	126 1.5×	15	487
Joseph Hatch United States	8	314 0.5×	181 1.1×	91 0.7×	56 0.6×	33 0.4×	18	451
Lisa A. Moulton United States	7	387 0.6×	352 2.2×	82 0.6×	96 1.0×	15 0.2×	8	626
Laura J. Sherrard United Kingdom	12	279 0.4×	211 1.3×	73 0.6×	48 0.5×	99 1.2×	23	443
J.L. Whitehouse United Kingdom	13	298 0.4×	193 1.2×	50 0.4×	62 0.7×	100 1.2×	39	498
B. Przyklenk Germany	8	280 0.4×	112 0.7×	112 0.9×	80 0.9×	60 0.7×	18	396
J. Maddison United Kingdom	7	429 0.6×	128 0.8×	96 0.7×	14 0.2×	97 1.1×	10	562
Douglas Conrad United States	8	151 0.2×	168 1.1×	71 0.6×	36 0.4×	19 0.2×	8	320

Countries citing papers authored by Jill M. Van Dalfsen

Since Specialization

Citations

This map shows the geographic impact of Jill M. Van Dalfsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill M. Van Dalfsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill M. Van Dalfsen more than expected).

Fields of papers citing papers by Jill M. Van Dalfsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill M. Van Dalfsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill M. Van Dalfsen. The network helps show where Jill M. Van Dalfsen may publish in the future.

Co-authorship network of co-authors of Jill M. Van Dalfsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jill M. Van Dalfsen. A scholar is included among the top collaborators of Jill M. Van Dalfsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill M. Van Dalfsen. Jill M. Van Dalfsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Nichols, David P., Sarah J. Morgan, M. Skalland, et al.. (2023). Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist. Journal of Clinical Investigation. 133(10). 106 indexed citations breakdown →

Rowe, Steven M., Sonya L. Heltshe, Tanja Gonska, et al.. (2014). Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 190(2). 175–184. 375 indexed citations breakdown →

Retsch‐Bogart, George, Jill M. Van Dalfsen, Bruce C. Marshall, et al.. (2014). Highly Effective Cystic Fibrosis Clinical Research Teams: Critical Success Factors. Journal of General Internal Medicine. 29(S3). 714–723. 5 indexed citations

VanDevanter, Donald R., et al.. (2013). In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients. Journal of the Pediatric Infectious Diseases Society. 4(2). 151–154. 7 indexed citations

VanDevanter, Donald R. & Jill M. Van Dalfsen. (2005). How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis?. Pediatric Pulmonology. 39(6). 504–506. 40 indexed citations

Dalfsen, Jill M. Van, et al.. (2002). Comparison of Two Culture Methods for Detection of Tobramycin-Resistant Gram-Negative Organisms in the Sputum of Patients with Cystic Fibrosis. Journal of Clinical Microbiology. 40(1). 26–30. 9 indexed citations

Burns, Jane L., Jill M. Van Dalfsen, Ribhi M. Shawar, et al.. (1999). Effect of Chronic Intermittent Administration of Inhaled Tobramycin on Respiratory Microbial Flora in Patients with Cystic Fibrosis. The Journal of Infectious Diseases. 179(5). 1190–1196. 237 indexed citations

Shawar, Ribhi M., Jill M. Van Dalfsen, C. Kendall Stover, et al.. (1997). Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrobial Agents and Chemotherapy. 41(3). 570–574. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact